Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 5.17
+0.10 (1.97%)
At close: Feb 10, 2026
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 1.26 billion as of February 10, 2026. Its market cap has increased by 178.72% in one year.
Market Cap
1.26B
Enterprise Value
921.32M
Revenue
308.69M
Ranking
n/a
PE Ratio
8.42
Stock Price
5.17
Market Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 1.26B, an increase of 945.56%. That is a compound annual growth rate of 24.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.29B | 23.54% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 2.91B |
| Flerie AB | 2.77B |
| Diamyd Medical AB | 2.25B |
| Egetis Therapeutics AB | 1.97B |
| BioInvent International AB | 1.71B |
| Genovis AB (publ.) | 1.35B |
| SynAct Pharma AB | 1.16B |
| Xspray Pharma AB | 968.42M |